Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized Study

Authors

Kaweh Shakery (ORCID: https://orcid.org/0000-0003-2350-7624)
U. Heinzel-Pleines (ORCID: https://orcid.org/0009-0005-7183-1973)
Frauke Friedrichs (ORCID: https://orcid.org/0009-0002-7005-8964)
Maximilian Feldmüller (ORCID: https://orcid.org/0000-0002-4316-2398)
RUTH DOROTHEE HOLZMANN
Stefan J. Jodl (ORCID: https://orcid.org/0009-0005-4268-3588)
Vidya Perera (ORCID: https://orcid.org/0000-0002-9055-0123)
Margitta Worm (ORCID: https://orcid.org/0000-0002-3449-1245)
Andrea Wagenfeld (ORCID: https://orcid.org/0000-0001-9648-4318)
Stefan Klein (ORCID: https://orcid.org/0000-0002-3351-6551)
Ruiping Zhang (ORCID: https://orcid.org/0000-0003-4095-7600)
Beate Rohde